Elevated levels of macrophage colony-stimulating factor in human fracture healing

Journal of Orthopaedic Research

Volumn 28, Issue 5, 2010, Pages 671-676

  Sarahrudi, Kambiz ^a   Mousavi, Mehdi ^b   Thomas, Anita ^a   Eipeldauer, Stefan ^a   Vécsei, Vilmos ^a   Pietschmann, Peter ^a   Aharinejad, Seyedhossein ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DANUBE HOSPITAL   (Austria)

Author keywords

CSF 1; Fracture healing; Human; M CSF

Indexed keywords

COLONY STIMULATING FACTOR 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FRACTURE; FRACTURE HEALING; FRACTURE NONUNION; HEMATOMA; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FEMORAL FRACTURES; FRACTURE HEALING; FRACTURES, BONE; HEMATOMA; HUMANS; HUMERAL FRACTURES; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; TIBIAL FRACTURES; YOUNG ADULT;

EID: 77949814099     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21048     Document Type: Article

References (40)

1. Gerstenfeld LC, Cullinane DM, Barnes GL, et al. 2003. Fracture healing as post-natal development process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88:373-384.
2. Zimmermann G, Henle P, Küsswetter M, et al. 2005. TGF-b 1 as a marker of delayed fracture healing. Bone 36:779-785.
3. Weiss S, Zimmermann G, Baumgart R, et al. 2005. Systemic regulation of angiogenesis and matrix degradation in bone regeneration-distraction osteogenesis compared to rigid fracture healing. Bone 37:781-790.
4. Einhorn TA. 1995. Enhancement of fracture healing. J Bone Joint Surg [Am] 77:940-956.
5. Joyce ME, Roberts AB, Sporn MB, et al. 1990. Transforming growth factor-beta and initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 21:199-209.
6. Street JT, Wang JH, Wu QD, et al. 2001. The angiogenic response to skeletal injury is preserved in the elderly. J Orthop Res 19:1057-1066.
7. Giannoudis PV, Pountos I, Morley J, et al. 2008. Growth factor release following femoral nailing. Bone 42:751-757.
8. Sarahrudi K, Thomas A, Braunsteiner T, et al. 2009. VEGF serum concentrations in patients with long bone fractures; a comparison between impaired and normal fracture healing. J Orthop Res 27:1293-1297.
9. Stanley ER, Berg KL, Einstein DB, et al. 1994. The biology and action of colony-stimulating facor-1. Stem Cells 12 (Suppl 1):15-24.
10. Marks SC. 1997. The structural basis for bone cell biology. Acta Med Dent Helv 2:141-157.
11. Aharinejad S, Marks SC, Bock P, et al. 1995. CSF-1 treatment promotes angiogenesis in the metaphysis of osteopetrotic (toothless, tl) rats. Bone 16:315-324.
12. Aharinejad S, Grossschmidt K, Franz P, et al. 1999. Auditory ossicle abnormalities and hearing loss in the toothless (osteopetrotic) mutation in the rat and their improvement after treatment with colony-stimulating factor-1. J Bone Miner Res 14:415-423.
13. Lacey DL, Timms E, Tan HL, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
14. Tanaka S, Takahashi N, Udagawa N, et al. 1993. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257-263.
15. Hattersley G, Owens J, Flanagan AM, et al. 1991. Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun 177:526-531.
16. Yao GQ, Sun BH, Weir EC, et al. 2002. A role for cell-surface CSF-1 in osteoblast-mediated osteoclastogenesis. Calcif Tissue Int 70:339-346.
17. Weir EC, Yao GQ, Chen Y, et al. 2000. Colony-stimulating factors and bone. In: Canalis E, editor, Skeletal growth factors. Philadelphia: Lippincott Williams & Wilkins; p 385-409.
18. Marks SC Jr, Mackay CA, Jackson ME, et al. 1993. The skeletal effects of colony-stimulating factor-1 in toothless (osteopetrotic) rats: persistent metaphyseal sclerosis and the failure to restore subepiphyseal osteoclasts. Bone 14:675-680.
19. Kreja L, Liedert A, Schmidt C, et al. 2007. Influence of receptor activator of nuclear factor (NF)-κB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteclast formation and activity. J Mol Hist 38:341-345.
20. Hodge JM, Kirkland MA, Nicholson GC. 2007. Multiple roles of M-CSF in human osteoclastogenesis. J Cell Biochem 15(102):759-768.
21. Sarahrudi K, Mousavi M, Grosschmidt K, et al. 2009. The impact of colony-stimulating factor-1 on fracture healing: an experimental study. J Orthop Res 27:36-41.
22. Bostrom MP. 1998. Expression of bone morphogenetic proteins in fracture healing. Clin Orthop 355(Suppl):116-123.
23. Bostorm MP, Lane JM, Berberia WS, et al. 1995. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13:357-367.
24. Si X, Jin Y, Yang L, et al. 1997. Expression of BMP 2 and TGF-beta1 mRNA during healing of the rabbit mandible. Eur J Oral Sci 105:325-330.
25. Yoshimura Y, Nomura S, Kawasaki S, et al. 2001. Colocalization of noggin and bone morphogenetic protein-4 during fracture healing. J Bone Miner Res 16:876-884.
26. He XE, Lu WZ, Tang KL, et al. 2003. Effects of bone morphogenetic protein and transforming growth factor beta on biomechanical property for fracture healing in rabbit ulna. Zhongguo Xiuffu Chongiijan Waike Zazhi 17:185-188.
27. Karsenty G, Wagner EF. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406.
28. Rodan Ga, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289:1508-1514.
29. Suda T, Takahashi N, Udagawa N, et al. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. End Rev 20:345-357.
30. Kong YY, Yoshida H, Sarosi I, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
31. Yasuda H, Shima N, Nakagawa N, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci USA 95:3597-3602.
32. Teitelbaum SL, Ross FP. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649.
33. Bab I, Gazit D, Muhlrad A, et al. 1988. Regenerating bone marrow produces a potent growth-promoting activity to osteogenic cells. Endocrinology 123:345-352.
34. Einhorn TA, Simon G, Devlin VJ, et al. 1990. The osteogenic response to distant skeletal injury. Bone Joint Surg [Am] 72:1374-1378.
35. Gazit D, Karmish M, Holzman L, et al. 1990. Regenerating marrow induces systemic increase in osteo- and chondrogenesis. Endocrinology 126:2607-2613.
36. Groeneveld EH, Burger EH. 2000. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 142: 9-21.
37. Weiss S, Zimmermann G, Pufe T, et al. 2008. The systemic angiogenic response during bone healing. Arch Orthop Trauma Surg 129:989-997.
38. Street J, Winter D, Wang JH, et al. 2000. Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res 378: 224-237.
39. Henle P, Zimmermann G, Weiss S. 2005. Matrix metalloproteinases and failed fracture healing. Bone 37:791-798.
40. Kon T, Cho TJ, Aizawa T, et al. 2001. Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004-1014.